Page 225 - Read Online
P. 225

dos Santos et al. J Cancer Metastasis Treat 2019;5:25  I  http://dx.doi.org/10.20517/2394-4722.2018.83                  Page 17 of 20

               6.   Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001;74:656-69.
               7.   Kou J, Dou D, Yang L. Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget 2017;8:81591-603.
               8.   Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, et al. Synergistic enhancement of carboplatin efficacy with photodynamic
                   therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res 2010;70:9319-28.
               9.   Ahn TG, Lee BR, Choi EY, Kim DW, Han SJ. Photodynamic therapy for breast cancer in a BALB/c mouse model. J Gynecol Oncol
                   2012;23:115-9.
               10.   Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Shakeri-Zadeh A, et al. Mitoxantrone as a prospective photosensitizer for
                   photodynamic therapy of breast cancer. Photodiagnosis Photodyn Ther 2012;9:46-51.
               11.   Agostinis P, Buytaert E, Breyssens H, Hendrickx N. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem
                   Photobiol Sci 2004;3:721-9.
               12.   Casas A, Di Venosa G, Hasan T, Al Batlle. Mechanisms of resistance to photodynamic therapy. Curr Med Chem 2011;18:2486-515.
               13.   Klotz LO, Kröncke KD, Sies H. Singlet oxygen-induced signaling effects in mammalian cells. Photochem Photobiol Sci 2003;2:88-94.
               14.   Oleinick NL, Morris RL, Nieminen A. Photodynamic Therapy-Induced Apoptosis. Apoptosis, Senescence, and Cancer; 2007. pp. 557-78.
               15.   Bacellar IOL, Tsubone TM, Pavani C, Baptista MS. Photodynamic efficiency: from molecular photochemistry to cell death. Int J Mol Sci
                   2015;16:20523-59.
               16.   Jensen TJ, Vicente MGH, Luguya R, Norton J, Fronczek FR, et al. Effect of overall charge and charge distribution on cellular uptake,
                   distribution and phototoxicity of cationic porphyrins in HEp2 cells. J Photochem Photobiol B Biol 2010;100:100-11.
               17.   Pavani C, Iamamoto Y, Baptista MS. Mechanism and efficiency of cell death of type II photosensitizers: effect of zinc chelation. Photochem
                   Photobiol 2012;88:774-81.
               18.   Bacellar IOL, Oliveira MC, Dantas LS, Costa EB, Junqueira HC, et al. Photosensitized membrane permeabilization requires contact-
                   dependent reactions between photosensitizer and lipids. J Am Chem Soc 2018;140:9606-15.
               19.   Mang TS, Allison R, Hewson G, Snider W, Moskowitz R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced
                   photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 1998;4:378-84.
               20.   Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett
                   2012;326:8-16.
               21.   Banerjee SM, MacRobert AJ, Mosse CA, Periera B, Bown SG, et al. Photodynamic therapy: inception to application in breast cancer. Breast
                   2017;31:105-13.
               22.   Lamberti MJ, Vittar NBR, Rivarola VA. Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of
                   tumor complexity. World J Clin Oncol 2014;5:901.
               23.   Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, et al. Photodynamic therapy - mechanisms, photosensitizers and
                   combinations. Biomed Pharmacother 2018;106:1098-107.
               24.   Abo-Zeid MAM, Abo-Elfadl MT, Mostafa SM. Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of
                   adenocarcinoma breast cancer and hepatocellular carcinoma cell lines. Photodiagnosis Photodyn Ther 2018;21:351-6.
               25.   Tardivo JP, Del Giglio A, de Oliveira CS, Gabrielli DS, Junqueira HC, et al. Methylene blue in photodynamic therapy: From basic
                   mechanisms to clinical applications. Photodiagnosis Photodyn Ther 2005;2:175-91.
               26.   Dos Santos AF, Terra LF, Wailemann RAM, Oliveira TC, Gomes VDM, et al. Methylene blue photodynamic therapy induces selective and
                   massive cell death in human breast cancer cells. BMC Cancer 2017;17:194.
               27.   Delaey E, van Laar F, De Vos D, Kamuhabwa A, Jacobs P, et al. A comparative study of the photosensitizing characteristics of some cyanine
                   dyes. J Photochem Photobiol B 2000;55:27-36.
               28.   Garg AD, Krysko D V, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated
                   molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 2012;61:215-21.
               29.   Panzarini E, Inguscio V, Fimia GM, Dini L. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of
                   damage-associated molecular patterns (DAMPs) in human HeLa cells. PLoS One 2014;9:e105778.
               30.   Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin
                   2011;61:250-81.
               31.   Cramers P, Ruevekamp M, Oppelaar H, Dalesio O, Baas P, et al. Foscan uptake and tissue distribution in relation to photodynamic efficacy.
                   Br J Cancer 2003;88:283-90.
               32.   Zheng X, Morgan J, Pandey SK, Chen Y, Tracy E, et al. Conjugation of 2-(1’-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to
                   carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J Med Chem 2009;52:4306-18.
               33.   Pogue BW, Ortel B, Chen N, Redmond RW, Hasan T. A photobiological and photophysical-based study of phototoxicity of two chlorins.
                   Cancer Res 2001;61:717-24.
               34.   Chen Z, Woodburn KW, Shi C, Adelman DC, Rogers C, et al. Photodynamic therapy with motexafin lutetium induces redox-sensitive
                   apoptosis of vascular cells. Arterioscler Thromb Vasc Biol 2001;21:759-64.
               35.   Spring BQ, Rizvi I, Xu N, Hasan T. The role of photodynamic therapy in overcoming cancer drug resistance. Photochem Photobiol Sci
                   2015;14:1476-91.
               36.   Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and
                   theranostics. Theranostics 2012;2:916-66.
               37.   Sandland J, Malatesti N, Boyle R. Porphyrins and related macrocycles: combining photosensitization with radio- or optical-imaging for next
                   generation theranostic agents. Photodiagnosis Photodyn Ther 2018;23:281-94.
               38.   Tsubone TM, Martins WK, Pavani C, Junqueira HC, Itri R, et al. Enhanced efficiency of cell death by lysosome-specific photodamage. Sci
                   Rep 2017;7:6734.
               39.   Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. Molecular mechanisms of cell death: recommendations of the nomenclature
                   committee on cell death 2018. Cell Death Differ 2018;25:486-541.
   220   221   222   223   224   225   226   227   228   229   230